2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
15
Papillomavirus Infections
9
Uterine Cervical Neoplasms
7
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
4
Neuroendocrine Tumors
4
Neoplasm Metastasis
4
Myasthenia Gravis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Autoimmune Diseases
3
Thyroid Diseases
2
Pancreatic Cyst
2
Neuroblastoma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Abortion, Spontaneous
2
Interventions
Metformin
2
Leuprolide
2
Collagenases
2
Clomiphene
2
tremelimumab
1
durvalumab
1
Temozolomide
1
Streptozocin
1
Spironolactone
1
Specimen Handling
1
Radiosurgery
1
Radiation
1
Propofol
1
Prednisone
1
Plasma Exchange
1
Nivolumab
1
Midazolam
1
Mercaptopurine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Infliximab
1
Immunoglobulins
1
High-Throughput Nucleotide Sequencing
1
Heavy Ion Radiotherapy
1
Fentanyl
1
FANG vaccine
1
Data Collection
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rare Diseases
×
Data Collection
×
Clear all
NCT05773651
2024-10-01
STEP 2 0
University Hospital Tuebingen
Recruiting
10,000 enrolled